Literature DB >> 14674890

Paraneoplastic pemphigus in association with Castleman's disease.

O V Nikolskaia1, C H Nousari, G J Anhalt.   

Abstract

BACKGROUND: Paraneoplastic pemphigus (PNP) is an autoimmune mucocutaneous disease associated with lymphoproliferative neoplasms, and frequently with a very rare tumour, Castleman's disease.
OBJECTIVES: To analyse the clinical history, immunopathological and histopathological findings in 28 patients with a confirmed diagnosis of PNP and Castleman's disease.
METHODS: Sera from all patients were assayed by indirect immunofluorescence (IF) and immunoprecipitation (IP) for plakin autoantibodies, immunoblotting for detection of plectin autoantibodies, and enzyme-linked immunosorbent assay for detection of desmoglein (Dsg)1 and Dsg3 autoantibodies.
RESULTS: Severe oral mucositis was observed in all patients, and lichenoid cutaneous lesions were seen in 19 of 28. Twenty cases of Castleman's disease were of the hyaline vascular type, four were of plasmacytoid type and four were of mixed type. Striking findings included pulmonary destruction leading to bronchiolitis obliterans in 26 patients and fatal outcome due to respiratory failure in 22 patients with pulmonary involvement. Histological findings included lichenoid and interface dermatitis with variable intraepithelial acantholysis. Direct IF showed deposition of IgG and C3 in the mouth and skin in 24 of 28 patients. However, indirect IF detected serum IgG autoantibodies in all patients. IP revealed IgG autoantibodies against desmoplakin I, envoplakin and periplakin in all cases, and against desmoplakin II and the 170-kDa antigen in 19 patients. Dsg3 and Dsg1 autoantibodies were present in 22 and 11 patients, respectively, and plectin autoantibodies in 23 patients.
CONCLUSIONS: PNP in association with Castleman's disease presents with severe oral mucositis and cutaneous lichenoid lesions. Serum autoantibodies against plakin proteins are the most diagnostic markers. Pulmonary injury with respiratory failure is the cause of death in most cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674890     DOI: 10.1111/j.1365-2133.2003.05659.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  32 in total

Review 1.  Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.

Authors:  Minhee Kim; Luca Borradori; Dédée F Murrell
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

2.  Castleman's Disease Presenting as Localized Abdominal Mass and Paraneoplastic Pemphigus.

Authors:  Santosh Kumar; Kshitij Bishnoi; Pragatheeswarane Murugavaithianathan; Vikas Kumar Panwar
Journal:  J Clin Imaging Sci       Date:  2016-02-26

3.  Improved outcomes after complete resection of underlying tumors for patients with paraneoplastic pemphigus: a single-center experience of 22 cases.

Authors:  Jun Zhang; Qi-lu Qiao; Xi-xue Chen; Ping Liu; Jian-xing Qiu; Hu Zhao; Jian-xun Zhao; Yu-cun Liu; Yuan-lian Wan
Journal:  J Cancer Res Clin Oncol       Date:  2011-02       Impact factor: 4.553

4.  Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice.

Authors:  Hayato Takahashi; Michiyoshi Kouno; Keisuke Nagao; Naoko Wada; Tsuyoshi Hata; Shuhei Nishimoto; Yoichiro Iwakura; Akihiko Yoshimura; Taketo Yamada; Masataka Kuwana; Hideki Fujii; Shigeo Koyasu; Masayuki Amagai
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

5.  Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.

Authors:  Shin Lee; Takahiro Yamauchi; Norito Ishii; Takashi Hashimoto; Keiichi Kinoshita; Shin Imamura; Kenichi Kamiya
Journal:  Int J Hematol       Date:  2017-08-08       Impact factor: 2.490

Review 6.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

7.  The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.

Authors:  Isabelle Schepens; Fabienne Jaunin; Nadja Begre; Ursula Läderach; Katrin Marcus; Takashi Hashimoto; Bertrand Favre; Luca Borradori
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

8.  A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman's disease.

Authors:  Yujiang Fang; Lei Zhao; Feng Yan; Xijun Cui; Yue Xia; Alicia Duren
Journal:  Med Oncol       Date:  2009-09-11       Impact factor: 3.064

9.  Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.

Authors:  Zsofia Miltenyi; Judit Toth; Andrea Gonda; Ildiko Tar; Eva Remenyik; Arpad Illes
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 10.  Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.

Authors:  Jean-François Cordier
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.